Alcoholic and Non-alcoholic Fatty Liver Disease

Alcoholic and Non-alcoholic Fatty Liver Disease

Alcoholic and Non-alcoholic Fatty Liver Disease

On this page

Overview & Definitions - Liver's Fatty Foes

  • Hepatic Steatosis: Abnormal lipid accumulation in >5% hepatocytes.
  • AFLD (Alcoholic FLD): Steatosis from chronic significant alcohol (e.g., >20-30g/d M, >10-20g/d F).
  • NAFLD (Non-alcoholic FLD): Steatosis with no/minimal alcohol; component of metabolic syndrome.
  • Steatohepatitis (ASH/NASH): Steatosis with inflammation & hepatocyte injury (e.g., ballooning). Histological spectrum of NAFLD and NASH

⭐ NAFLD is the most common chronic liver disease, with rising prevalence globally.

Pathogenesis Pathways - How Fat Happens

  • ↑ FA Delivery/Uptake to Liver:
    • NAFLD: Insulin resistance (IR) in adipose tissue → ↑ peripheral lipolysis → ↑ FFAs to liver.
  • ↑ De Novo Lipogenesis (DNL) in Liver:
    • AFLD: Ethanol metabolism → ↑NADH/NAD+ ratio, shunting substrates to FA synthesis.
    • NAFLD: IR & hyperinsulinemia activate SREBP-1c (key lipogenic TF).
  • ↓ FA β-oxidation in Mitochondria:
    • AFLD: ↑NADH/NAD+ ratio inhibits mitochondrial β-oxidation.
    • NAFLD: Mitochondrial dysfunction & oxidative stress impair FA breakdown.
  • ↓ VLDL Export from Liver:
    • AFLD: Acetaldehyde impairs microtubule function & apoprotein synthesis for VLDL.
    • NAFLD: Impaired ApoB-100 synthesis or VLDL assembly/secretion.

⭐ PNPLA3 variants link to NAFLD & alcoholic cirrhosis, impairing triglyceride hydrolysis.

Microscopic Mayhem - Biopsy Breakdown

  • Steatosis: Macrovesicular (large lipid droplets displacing nucleus).
    • NAFLD: Often Zone 3 (perivenular) predominant.
  • Hepatocyte Injury:
    • Ballooning degeneration (swollen hepatocytes, rarefied cytoplasm).
    • Apoptotic bodies (acidophilic).
  • Mallory-Denk Bodies (MDBs):
    • Eosinophilic, irregular, ropey intracytoplasmic inclusions (cytokeratins 8/18).
    • Highly characteristic of AFLD; also seen in NASH.
  • Inflammation:
    • AFLD: Predominantly neutrophils, often surrounding damaged hepatocytes (satellitosis).
    • NASH: Mixed lobular infiltrate (lymphocytes, macrophages, fewer neutrophils).
  • Fibrosis:
    • Perisinusoidal/pericellular ("chicken-wire") pattern, typically begins in Zone 3.
    • Can progress to bridging fibrosis and ultimately cirrhosis.

Liver biopsy: steatosis, ballooning, inflammation

⭐ Mallory-Denk bodies, composed of tangled cytokeratin filaments (CK8/18) and ubiquitin, are a key indicator of severe hepatocyte injury.

Clinical Clues & Diagnosis - Spotting the Steatosis

  • Symptoms: Often silent. NAFLD linked to metabolic syndrome; AFLD to alcohol use. Fatigue, RUQ discomfort possible.
  • Key Labs:
    • AFLD: AST/ALT ratio > 2 (📌 Alcohol Superior to Alanine), ↑GGT.
    • NAFLD: ALT > AST (ratio < 1).
    • Assess for fibrosis: FIB-4 score $ (Age \times AST) / (Platelets \times \sqrt{ALT}) $.
  • Imaging:
    • Ultrasound (USG): Initial, shows hyperechoic "bright liver".
    • Transient Elastography (FibroScan): Measures steatosis (CAP) & fibrosis.
  • Liver Biopsy: Gold standard for diagnosis/staging (e.g., NASH if NAS ≥ 5). AFLD: Mallory-Denk bodies.

Ultrasound: Normal vs. Grade 1 Fatty Liver

⭐ In AFLD, the AST:ALT ratio is typically > 2, whereas in NAFLD, it's usually < 1. This difference is a key diagnostic clue.

Progression & Perils - Fatty Liver's Fate

  • Silent Progression: Often asymptomatic until advanced stages.
  • Fibrosis is Key: Determines prognosis; bridging fibrosis (F3) to cirrhosis (F4) critical.
  • Cirrhotic Complications: Portal hypertension, liver failure, coagulopathy.
  • HCC Risk: Significantly ↑ with cirrhosis; also present in non-cirrhotic NASH.

⭐ About 20-30% of NASH patients progress to cirrhosis; HCC risk ↑ 5-10 fold with cirrhosis.

Fatty Liver Disease Progression

High‑Yield Points - ⚡ Biggest Takeaways

  • NAFLD is strongly associated with metabolic syndrome and insulin resistance; AFLD with chronic alcohol abuse.
  • Both show steatosis (fatty liver), which can progress to steatohepatitis, fibrosis, and cirrhosis.
  • Mallory-Denk bodies (intracytoplasmic hyaline) are characteristic, especially in AFLD.
  • An AST/ALT ratio >2 is suggestive of AFLD; ALT > AST is more common in NAFLD.
  • Weight loss and lifestyle modification are crucial for NAFLD management; alcohol abstinence is essential for AFLD.
  • Both conditions significantly increase the risk of hepatocellular carcinoma (HCC), particularly with established cirrhosis.

Practice Questions: Alcoholic and Non-alcoholic Fatty Liver Disease

Test your understanding with these related questions

A 50-year-old man with a history of alcohol abuse is found to have elevated liver enzymes, and a liver biopsy shows the microscopic features of steatosis. If the patient abstains from further drinking, this condition will most likely evolve into which of the following?

1 of 5

Flashcards: Alcoholic and Non-alcoholic Fatty Liver Disease

1/10

_____ pattern is seen on trichrome staining of liver biopsy specimen in alcoholic hepatitis

TAP TO REVEAL ANSWER

_____ pattern is seen on trichrome staining of liver biopsy specimen in alcoholic hepatitis

Chicken-wire fence

browseSpaceflip

Enjoying this lesson?

Get full access to all lessons, practice questions, and more.

Start Your Free Trial